English

Cellceutix CORP

EDGAR

CTIX Quarterly report (10-Q) · filed 2023-11-20

81 filing records in this dataset, filed from 2006-11-15 to 2023-11-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-677 thousand USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -677000 USD Source

Cash and cash equivalents: 864 thousand USD 2023-09-30 Source
Exact value

864000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 121 million shares 2016-03-31 Source
Exact value

121440536 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 0 USD · 2022-10-01 – 2022-12-31 Source
Revenue: 0 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 0 USD · 2022-07-01 – 2023-06-30 Source
Revenue: 0 USD · 2022-07-01 – 2023-03-31 Source
Revenue: 0 USD · 2023-07-01 – 2023-09-30 Source

Net income

-2.62 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -361000 USD · 2022-10-01 – 2022-12-31 Source
Net income: -698000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -3168000 USD · 2022-07-01 – 2023-06-30 Source
Net income: -2487000 USD · 2022-07-01 – 2023-03-31 Source
Net income: -880000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-1.99 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -1268000 USD · 2022-07-01 – 2022-12-31 Source
Operating cash flow: -791000 USD · 2022-07-01 – 2022-09-30 Source
Operating cash flow: -1737000 USD · 2022-07-01 – 2023-03-31 Source
Operating cash flow: -1268000 USD · 2022-07-01 – 2022-12-31 Source
Operating cash flow: -2106000 USD · 2022-07-01 – 2023-06-30 Source
Operating cash flow: -1737000 USD · 2022-07-01 – 2023-03-31 Source
Operating cash flow: -677000 USD · 2023-07-01 – 2023-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-20.

Financial data available through: 2023-06-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2023-06-30
Operating income: 11 of 11 periods available· newest 2023-06-30
Net income: 11 of 11 periods available· newest 2023-06-30
Operating cash flow: 11 of 11 periods available· newest 2023-06-30
capital expenditure: No compatible figures in this window
Total assets: 5 of 11 periods available· newest 2023-06-30
Total liabilities: 5 of 11 periods available· newest 2023-06-30
Current assets: 5 of 11 periods available· newest 2023-06-30
Current liabilities: 5 of 11 periods available· newest 2023-06-30
Cash and cash equivalents: 5 of 11 periods available· newest 2023-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-100%

Prior period

USD 18,000

2021-07-01 – 2022-06-30
Current period

USD 0

2022-07-01 – 2023-06-30

Exact inputs and evidence

0 − 18000 = -18000 USD

18000 USD · 2021-07-01 – 2022-06-30
Inspect prior input Prior source
0 USD · 2022-07-01 – 2023-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Cellceutix CORP · 2023-06-30 Cellceutix CORP (edgar:1355250) Year-over-year change in Revenue: -18000 USD Concept: fundies:Revenue Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#684379 Filing: 000147793223007158 Input fundies:Revenue: 18000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#685010 Filing: 000147793223007158
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.87 million

Prior period

−USD 7.04 million

2021-07-01 – 2022-06-30
Current period

−USD 3.17 million

2022-07-01 – 2023-06-30

Exact inputs and evidence

-3168000 − -7041000 = 3873000 USD

-7041000 USD · 2021-07-01 – 2022-06-30
Inspect prior input Prior source
-3168000 USD · 2022-07-01 – 2023-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Cellceutix CORP · 2023-06-30 Cellceutix CORP (edgar:1355250) Year-over-year change in Net income: 3873000 USD Concept: fundies:NetIncome Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3168000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#888534 Filing: 000147793223007158 Input fundies:NetIncome: -7041000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#889065 Filing: 000147793223007158
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 4.17 million

Prior period

−USD 6.28 million

2021-07-01 – 2022-06-30
Current period

−USD 2.11 million

2022-07-01 – 2023-06-30

Exact inputs and evidence

-2106000 − -6280000 = 4174000 USD

-6280000 USD · 2021-07-01 – 2022-06-30
Inspect prior input Prior source
-2106000 USD · 2022-07-01 – 2023-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Cellceutix CORP · 2023-06-30 Cellceutix CORP (edgar:1355250) Year-over-year change in Operating cash flow: 4174000 USD Concept: fundies:OperatingCashFlow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2106000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#910293 Filing: 000147793223007158 Input fundies:OperatingCashFlow: -6280000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#910905 Filing: 000147793223007158
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2022-07-01 – 2023-06-30

Revenue USD 0
Operating costs Derived USD 3.11 million
Operating income −USD 3.11 million
Tax, interest and other Derived USD 57,000
Net income −USD 3.17 million

Cash

Operating cash flow −USD 2.11 million
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Not shown: operating income or net income is not reported.
2020 Operating loss: operating costs were 1,196% of revenue.
2021 Not shown: operating income or net income is not reported.
2022 Operating loss: operating costs were 38,550% of revenue.
2023 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2018-07-01 – 2019-06-30	0	6451000 Derived	-6451000	2230000 Derived	-8681000	Unavailable	Source 2018-07-01 – 2019-06-30: 0 USD Inspect Revenue Open source 2018-07-01 – 2019-06-30: -6451000 USD Inspect Operating Income Open source 2018-07-01 – 2019-06-30: -8681000 USD Inspect Net Income Open source 2018-07-01 – 2019-06-30: -6332000 USD Inspect Operating Cash Flow Open source
2020 2019-07-01 – 2020-06-30	423000	5058000 Derived	-4635000	2013000 Derived	-6648000	Unavailable	Source 2019-07-01 – 2020-06-30: 423000 USD Inspect Revenue Open source 2019-07-01 – 2020-06-30: -4635000 USD Inspect Operating Income Open source 2019-07-01 – 2020-06-30: -6648000 USD Inspect Net Income Open source 2019-07-01 – 2020-06-30: -4156000 USD Inspect Operating Cash Flow Open source
2021 2020-07-01 – 2021-06-30	0	9015000 Derived	-9015000	4857000 Derived	-13872000	Unavailable	Source 2020-07-01 – 2021-06-30: 0 USD Inspect Revenue Open source 2020-07-01 – 2021-06-30: -9015000 USD Inspect Operating Income Open source 2020-07-01 – 2021-06-30: -13872000 USD Inspect Net Income Open source 2020-07-01 – 2021-06-30: -9495000 USD Inspect Operating Cash Flow Open source
2022 2021-07-01 – 2022-06-30	18000	6939000 Derived	-6921000	120000 Derived	-7041000	Unavailable	Source 2021-07-01 – 2022-06-30: 18000 USD Inspect Revenue Open source 2021-07-01 – 2022-06-30: -6921000 USD Inspect Operating Income Open source 2021-07-01 – 2022-06-30: -7041000 USD Inspect Net Income Open source 2021-07-01 – 2022-06-30: -6280000 USD Inspect Operating Cash Flow Open source
2023 2022-07-01 – 2023-06-30	0	3111000 Derived	-3111000	57000 Derived	-3168000	Unavailable	Source 2022-07-01 – 2023-06-30: 0 USD Inspect Revenue Open source 2022-07-01 – 2023-06-30: -3111000 USD Inspect Operating Income Open source 2022-07-01 – 2023-06-30: -3168000 USD Inspect Net Income Open source 2022-07-01 – 2023-06-30: -2106000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Revenue	0	Revenue: 0 Open source
20202020-06-30	Revenue	423000	Revenue: 423000 Open source
20212021-06-30	Revenue	0	Revenue: 0 Open source
20222022-06-30	Revenue	18000	Revenue: 18000 Open source
20232023-06-30	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Year over year	No prior comparable period	Revenue: 0 Open source
20202020-06-30	Year over year	No prior comparable period	Revenue: 423000 Open source Revenue: 0 Open source
20212021-06-30	Year over year	-100%	Revenue: 0 Open source Revenue: 423000 Open source
20222022-06-30	Year over year	No prior comparable period	Revenue: 18000 Open source Revenue: 0 Open source
20232023-06-30	Year over year	-100%	Revenue: 0 Open source Revenue: 18000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -38,450% 2022

Net margin -39,116.7% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Operating margin	Not reported	Operating Income: -6451000 Open source Revenue: 0 Open source
20202020-06-30	Operating margin	-1,095.7%	Operating Income: -4635000 Open source Revenue: 423000 Open source
20212021-06-30	Operating margin	Not reported	Operating Income: -9015000 Open source Revenue: 0 Open source
20222022-06-30	Operating margin	-38,450%	Operating Income: -6921000 Open source Revenue: 18000 Open source
20232023-06-30	Operating margin	Not reported	Operating Income: -3111000 Open source Revenue: 0 Open source
20192019-06-30	Net margin	Not reported	Net Income: -8681000 Open source Revenue: 0 Open source
20202020-06-30	Net margin	-1,571.6%	Net Income: -6648000 Open source Revenue: 423000 Open source
20212021-06-30	Net margin	Not reported	Net Income: -13872000 Open source Revenue: 0 Open source
20222022-06-30	Net margin	-39,116.7%	Net Income: -7041000 Open source Revenue: 18000 Open source
20232023-06-30	Net margin	Not reported	Net Income: -3168000 Open source Revenue: 0 Open source
20192019-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6332000 Open source
20202020-06-30	Free cash flow margin	Not reported	Revenue: 423000 Open source Operating Cash Flow: -4156000 Open source
20212021-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -9495000 Open source
20222022-06-30	Free cash flow margin	Not reported	Revenue: 18000 Open source Operating Cash Flow: -6280000 Open source
20232023-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2106000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.1M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Operating cash flow	-6332000	Operating Cash Flow: -6332000 Open source
20202020-06-30	Operating cash flow	-4156000	Operating Cash Flow: -4156000 Open source
20212021-06-30	Operating cash flow	-9495000	Operating Cash Flow: -9495000 Open source
20222022-06-30	Operating cash flow	-6280000	Operating Cash Flow: -6280000 Open source
20232023-06-30	Operating cash flow	-2106000	Operating Cash Flow: -2106000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Free cash flow	Unavailable	Operating Cash Flow: -6332000 Open source
20202020-06-30	Free cash flow	Unavailable	Operating Cash Flow: -4156000 Open source
20212021-06-30	Free cash flow	Unavailable	Operating Cash Flow: -9495000 Open source
20222022-06-30	Free cash flow	Unavailable	Operating Cash Flow: -6280000 Open source
20232023-06-30	Free cash flow	Unavailable	Operating Cash Flow: -2106000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

72.9% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Liabilities / assets	202.1%	Total Liabilities: 8175000 Open source Total Assets: 4046000 Open source
20202020-06-30	Liabilities / assets	84.2%	Total Liabilities: 7786000 Open source Total Assets: 9248000 Open source
20212021-06-30	Liabilities / assets	47.5%	Total Liabilities: 6790000 Open source Total Assets: 14299000 Open source
20222022-06-30	Liabilities / assets	54.4%	Total Liabilities: 5649000 Open source Total Assets: 10379000 Open source
20232023-06-30	Liabilities / assets	72.9%	Total Liabilities: 5478000 Open source Total Assets: 7517000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.33× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Current assets / current liabilities	0.09×	Current Assets: 625000 Open source Current Liabilities: 7296000 Open source
20202020-06-30	Current assets / current liabilities	0.83×	Current Assets: 6110000 Open source Current Liabilities: 7369000 Open source
20212021-06-30	Current assets / current liabilities	1.63×	Current Assets: 10689000 Open source Current Liabilities: 6538000 Open source
20222022-06-30	Current assets / current liabilities	0.82×	Current Assets: 3952000 Open source Current Liabilities: 4808000 Open source
20232023-06-30	Current assets / current liabilities	0.33×	Current Assets: 1634000 Open source Current Liabilities: 5021000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2013-07-01 – 2014-06-30	−USD 8.25 million Exact value Exact value: -8247000 USD 2013-07-01 – 2014-06-30: -8247000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2014-06-30 Cellceutix CORP (edgar:1355250) Net Income: -8247000 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: -8247000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793216012448/ctix-20160630.xml#112937 Filing: 000147793216012448 The citation records this snapshot. The page link may show a newer release later.	−USD 7.51 million Exact value Exact value: -7510000 USD 2013-07-01 – 2014-06-30: -7510000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2014-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -7510000 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7510000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793216012448/ctix-20160630.xml#124174 Filing: 000147793216012448 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-07-01 – 2015-06-30	−USD 13.15 million Exact value Exact value: -13145000 USD 2014-07-01 – 2015-06-30: -13145000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2015-06-30 Cellceutix CORP (edgar:1355250) Net Income: -13145000 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:NetIncome: -13145000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793217004400/ipix-20170630.xml#295599 Filing: 000147793217004400 The citation records this snapshot. The page link may show a newer release later.	−USD 13.07 million Exact value Exact value: -13071000 USD 2014-07-01 – 2015-06-30: -13071000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2015-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -13071000 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13071000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793217004400/ipix-20170630.xml#304020 Filing: 000147793217004400 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-07-01 – 2016-06-30	−USD 12.85 million Exact value Exact value: -12852000 USD 2015-07-01 – 2016-06-30: -12852000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2016-06-30 Cellceutix CORP (edgar:1355250) Net Income: -12852000 USD Concept: fundies:NetIncome Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:NetIncome: -12852000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793217004400/ipix-20170630.xml#297588 Filing: 000147793217004400 The citation records this snapshot. The page link may show a newer release later.	−USD 9.89 million Exact value Exact value: -9887000 USD 2015-07-01 – 2016-06-30: -9887000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2016-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -9887000 USD Concept: fundies:OperatingCashFlow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9887000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793217004400/ipix-20170630.xml#304472 Filing: 000147793217004400 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-07-01 – 2017-06-30	−USD 15.54 million Exact value Exact value: -15536000 USD 2016-07-01 – 2017-06-30: -15536000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2017-06-30 Cellceutix CORP (edgar:1355250) Net Income: -15536000 USD Concept: fundies:NetIncome Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15536000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793218004457/ipix-20180630.xml#126752 Filing: 000147793218004457 The citation records this snapshot. The page link may show a newer release later.	−USD 11.71 million Exact value Exact value: -11711000 USD 2016-07-01 – 2017-06-30: -11711000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2017-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -11711000 USD Concept: fundies:OperatingCashFlow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11711000 USD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793218004457/ipix-20180630.xml#943497 Filing: 000147793218004457 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-07-01 – 2018-06-30	−USD 16.36 million Exact value Exact value: -16362000 USD 2017-07-01 – 2018-06-30: -16362000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2018-06-30 Cellceutix CORP (edgar:1355250) Net Income: -16362000 USD Concept: fundies:NetIncome Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:NetIncome: -16362000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793219005611/ipix-20190630.xml#154588 Filing: 000147793219005611 The citation records this snapshot. The page link may show a newer release later.	−USD 13.28 million Exact value Exact value: -13278000 USD 2017-07-01 – 2018-06-30: -13278000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2018-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -13278000 USD Concept: fundies:OperatingCashFlow Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13278000 USD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793219005611/ipix-20190630.xml#194091 Filing: 000147793219005611 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-07-01 – 2019-06-30	−USD 8.68 million Exact value Exact value: -8681000 USD 2018-07-01 – 2019-06-30: -8681000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2019-06-30 Cellceutix CORP (edgar:1355250) Net Income: -8681000 USD Concept: fundies:NetIncome Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:NetIncome: -8681000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793220005387/ipix-20200630.xml#182219 Filing: 000147793220005387 The citation records this snapshot. The page link may show a newer release later.	−USD 6.33 million Exact value Exact value: -6332000 USD 2018-07-01 – 2019-06-30: -6332000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2019-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -6332000 USD Concept: fundies:OperatingCashFlow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6332000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793220005387/ipix-20200630.xml#216663 Filing: 000147793220005387 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-07-01 – 2020-06-30	−USD 6.65 million Exact value Exact value: -6648000 USD 2019-07-01 – 2020-06-30: -6648000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2020-06-30 Cellceutix CORP (edgar:1355250) Net Income: -6648000 USD Concept: fundies:NetIncome Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:NetIncome: -6648000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793221006717/ipix-20210630.xml#143010 Filing: 000147793221006717 The citation records this snapshot. The page link may show a newer release later.	−USD 4.16 million Exact value Exact value: -4156000 USD 2019-07-01 – 2020-06-30: -4156000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2020-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -4156000 USD Concept: fundies:OperatingCashFlow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4156000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793221006717/ipix-20210630.xml#212241 Filing: 000147793221006717 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-07-01 – 2021-06-30	−USD 13.87 million Exact value Exact value: -13872000 USD 2020-07-01 – 2021-06-30: -13872000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2021-06-30 Cellceutix CORP (edgar:1355250) Net Income: -13872000 USD Concept: fundies:NetIncome Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:NetIncome: -13872000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793222007292/ipix_10k.htm#839338 Filing: 000147793222007292 The citation records this snapshot. The page link may show a newer release later.	−USD 9.5 million Exact value Exact value: -9495000 USD 2020-07-01 – 2021-06-30: -9495000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2021-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -9495000 USD Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9495000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793222007292/ipix_10k.htm#936344 Filing: 000147793222007292 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2021-07-01 – 2022-06-30	−USD 7.04 million Exact value Exact value: -7041000 USD 2021-07-01 – 2022-06-30: -7041000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2022-06-30 Cellceutix CORP (edgar:1355250) Net Income: -7041000 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:NetIncome: -7041000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#889065 Filing: 000147793223007158 The citation records this snapshot. The page link may show a newer release later.	−USD 6.28 million Exact value Exact value: -6280000 USD 2021-07-01 – 2022-06-30: -6280000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2022-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -6280000 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6280000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#910905 Filing: 000147793223007158 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2022-07-01 – 2023-06-30	−USD 3.17 million Exact value Exact value: -3168000 USD 2022-07-01 – 2023-06-30: -3168000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cellceutix CORP · 2023-06-30 Cellceutix CORP (edgar:1355250) Net Income: -3168000 USD Concept: fundies:NetIncome Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3ANetIncome&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3168000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#888534 Filing: 000147793223007158 The citation records this snapshot. The page link may show a newer release later.	−USD 2.11 million Exact value Exact value: -2106000 USD 2022-07-01 – 2023-06-30: -2106000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cellceutix CORP · 2023-06-30 Cellceutix CORP (edgar:1355250) Operating Cash Flow: -2106000 USD Concept: fundies:OperatingCashFlow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T19:14:01Z Snapshot: 7e544b7f67318ad2d56b00809429cafeb1738a2c485b0ba085aa7ac0adced633 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1355250/explain?concept=fundies%3AOperatingCashFlow&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2106000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm#910293 Filing: 000147793223007158 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

81 filings · 2,387 latest values · 2,387 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001355250, 1355250, CTIX, ctix, edgar:1355250, ipix

Also known as CELLCEUTIX CORP, Cellceutix CORP, EconoShare, Inc., INNOVATION PHARMACEUTICALS INC., Innovation Pharmaceuticals Inc.

Cellceutix CORP

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2023 2022-07-01 – 2023-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation